CRESTOR Athero Imaging Head to Head IVUS Study - SATURN

Exclusion Criteria

• - Use of certain lipid-lowering medication for more than 3 months within the previous 12 months. Longer periods of treatment are not permitted because of the potential effects of such therapy on coronary atherosclerosis.
• - Patients who have symptoms consistent with moderate or greater severity of Congestive Heart Failure (CHF).
• - Clinically significant heart disease which, in the opinion of the Principal Investigator (or designee), is likely to require coronary bypass surgery, cardiac transplantation, surgical repair and/or replacement during the course of the study